Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism

Cited in blog · Science Translational Medicine, 16(748). · 2024

Zhou, Y., et al. (2024). Psilocybin prevents chemotherapy-induced neuropathic pain through a 5-HT2A receptor-dependent mechanism. *Science Translational Medicine*, 16(748).